Public Employees Retirement Association of Colorado Decreases Holdings in Innospec Inc. (NASDAQ:IOSP)

Public Employees Retirement Association of Colorado lowered its position in Innospec Inc. (NASDAQ:IOSPFree Report) by 7.0% in the 2nd quarter, Holdings Channel reports. The institutional investor owned 3,306 shares of the specialty chemicals company’s stock after selling 249 shares during the period. Public Employees Retirement Association of Colorado’s holdings in Innospec were worth $409,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. TFO Wealth Partners LLC boosted its stake in shares of Innospec by 29,800.0% in the 4th quarter. TFO Wealth Partners LLC now owns 299 shares of the specialty chemicals company’s stock valued at $37,000 after purchasing an additional 298 shares in the last quarter. DekaBank Deutsche Girozentrale purchased a new stake in Innospec during the first quarter valued at about $66,000. CWM LLC grew its stake in shares of Innospec by 239.6% during the second quarter. CWM LLC now owns 635 shares of the specialty chemicals company’s stock valued at $78,000 after buying an additional 448 shares during the last quarter. Motco purchased a new position in shares of Innospec in the first quarter worth about $132,000. Finally, EntryPoint Capital LLC bought a new stake in shares of Innospec in the 1st quarter valued at about $147,000. 96.64% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, StockNews.com lowered Innospec from a “strong-buy” rating to a “buy” rating in a research report on Thursday, August 8th.

Get Our Latest Stock Analysis on IOSP

Insider Buying and Selling at Innospec

In other news, CFO Ian Cleminson sold 3,398 shares of Innospec stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $114.74, for a total value of $389,886.52. Following the sale, the chief financial officer now directly owns 12,996 shares in the company, valued at approximately $1,491,161.04. The sale was disclosed in a filing with the SEC, which is available through this link. 1.52% of the stock is currently owned by corporate insiders.

Innospec Stock Up 2.3 %

Shares of NASDAQ IOSP opened at $113.81 on Friday. The firm’s fifty day moving average is $114.49 and its 200 day moving average is $121.45. Innospec Inc. has a 52 week low of $95.69 and a 52 week high of $133.71. The company has a market cap of $2.84 billion, a price-to-earnings ratio of 19.32 and a beta of 1.08.

Innospec (NASDAQ:IOSPGet Free Report) last released its quarterly earnings data on Tuesday, August 6th. The specialty chemicals company reported $1.39 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.37 by $0.02. The firm had revenue of $435.00 million for the quarter, compared to analysts’ expectations of $468.73 million. Innospec had a net margin of 7.90% and a return on equity of 14.15%. The company’s revenue for the quarter was down 9.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.28 earnings per share. Equities research analysts anticipate that Innospec Inc. will post 5.95 earnings per share for the current year.

About Innospec

(Free Report)

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.

See Also

Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc. (NASDAQ:IOSPFree Report).

Institutional Ownership by Quarter for Innospec (NASDAQ:IOSP)

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.